Cambrium
9 known investors
Cambrium designs and produces enzymes, polymers, and peptides using a molecular design platform and biological systems, aiming to create high-performance materials. It serves multiple industries including textiles, automotive, cosmetics, and construction where material performance is a priority.
BiotechDeep TechNew Materials
Investors · 9
DG Daiwa Ventures
Earth Venture Capital
Gradient VenturesSan Francisco · $100K – $10M
.jpeg){kind=logo}
JuniperClarksville · $100K – $1.5M
SBI Ventures Europe GmbHBerlin
Transpose Platform ManagementHouston
HOF CapitalreportedNew York · $25K – $15M
Merantix Capitalreported · 2 sourcesBerlin · $540K – $4.3M
Valor Equity PartnersreportedChicago
In the news
Frequently asked questions
- What does Cambrium do?
- Cambrium designs and produces enzymes, polymers, and peptides using a molecular design platform and biological systems, aiming to create high-performance materials. It serves multiple industries including textiles, automotive, cosmetics, and construction where material performance is a priority.
- Who are Cambrium's investors?
- Cambrium's investors include DG Daiwa Ventures, Earth Venture Capital, Gradient Ventures, Juniper, SBI Ventures Europe GmbH, Transpose Platform Management, HOF Capital, Merantix Capital and 1 more.